Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

AACR 2009

18 - 22 Apr 2009
Videos

Study of the extra cellular matrix around cancer cells and 3D assays

Dr Mina Bissell - Lawrence Berkeley National Laboratory, USA
Study of the extra cellular matrix around cancer cells and 3D assays ( Dr Mina Bissell - Lawrence Berkeley National Laboratory, USA )
8 Jul 2009

MicroRNAs regulating cancer stem cell self renewal

Dr Michael Clarke - Stanford School of Medicine, USA
MicroRNAs regulating cancer stem cell self renewal ( Dr Michael Clarke - Stanford School of Medicine, USA )
8 Jul 2009

Studying genetics behind drug resistance using cell culture models

Dr René Bernards - Netherlands Cancer Institute, Amsterdam
Studying genetics behind drug resistance using cell culture models ( Dr René Bernards - Netherlands Cancer Institute, Amsterdam )
8 Jul 2009

Selecting appropriate first line lung cancer therapy

Dr Paul Bunn - University of Colorado, Denver, USA
Selecting appropriate first line lung cancer therapy ( Dr Paul Bunn - University of Colorado, Denver, USA )
8 Jul 2009

Mouse models to ID genetic controls and 3D models to help personalise therapy

Dr Marco Pieroti - National Cancer Institute, Milan, Italy
Mouse models to ID genetic controls and 3D models to help personalise therapy ( Dr Marco Pieroti - National Cancer Institute, Milan, Italy )
8 Jul 2009

Genetic determinants for breast cancer spread

Dr Kent Hunter - National Cancer Institute, Bethesda, USA
Genetic determinants for breast cancer spread ( Dr Kent Hunter - National Cancer Institute, Bethesda, USA )
8 Jul 2009

Activating p53 and cell senescence to regress tumours

Dr Karen Vousden - Beatson Institute for Cancer Research, Glasgow
Activating p53 and cell senescence to regress tumours ( Dr Karen Vousden - Beatson Institute for Cancer Research, Glasgow )
8 Jul 2009

AACR 2009: Circulating tumour cells as biomarkers

Dr Howard Scher - Sloan Kettering Memorial Cancer Center
AACR 2009: Circulating tumour cells as biomarkers ( Dr Howard Scher - Sloan Kettering Memorial Cancer Center )
5 Jun 2009

AACR 2009: Tackling the p53 gene and side effects

Professor David Lane - Director of the Cancer Research UK Transformation Research Group, University of Dundee
AACR 2009: Tackling the p53 gene and side effects ( Professor David Lane - Director of the Cancer Research UK Transformation Research Group, University of Dundee )
18 May 2009

AACR 2009: Common genetic variations and predisposition to cancer

Prof Bruce Ponder - Cancer Research UK, Cambridge Institute
AACR 2009: Common genetic variations and predisposition to cancer ( Prof Bruce Ponder - Cancer Research UK, Cambridge Institute )
14 May 2009

AACR 2009: Anti-angiogenics to tackle brain and prostate tumours

Prof Gabriele Bergers - University of California, San Francisco
AACR 2009: Anti-angiogenics to tackle brain and prostate tumours ( Prof Gabriele Bergers - University of California, San Francisco )
14 May 2009

AACR 2009: 100 years of AACR

Dr Margaret Foti - CEO of the American Association for Cancer Research
AACR 2009: 100 years of AACR ( Dr Margaret Foti - CEO of the American Association for Cancer Research )
14 May 2009

AACR 2009: Cancer stem cells and leukaemia

Prof Craig Jordan - James P Wilmot Cancer Center University of Rochester School of Medicine
AACR 2009: Cancer stem cells and leukaemia ( Prof Craig Jordan - James P Wilmot Cancer Center University of Rochester School of Medicine )
14 May 2009

AACR 2009: Chemokine inhibitors to prevent tumour growth

Prof Alberto Mantovani - Professor of General Pathology, University of Milan
AACR 2009: Chemokine inhibitors to prevent tumour growth ( Prof Alberto Mantovani - Professor of General Pathology, University of Milan )
14 May 2009

AACR 2009: Enhancement of recruitment of african-americans to cancer trials

Dr Debra Wujcik - Director of Cancer Clinical Trials, Meharry Medical College / The Vanderbilt-Ingram Cancer Center, USA
AACR 2009: Enhancement of recruitment of african-americans to cancer trials ( Dr Debra Wujcik - Director of Cancer Clinical Trials, Meharry Medical College / The Vanderbilt-Ingram Cancer Center, USA )
7 May 2009

AACR 2009: Determinants of screening colonoscopy among african-american older adults

Prof Jean Ford - Dept of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, USA
AACR 2009: Determinants of screening colonoscopy among african-american older adults ( Prof Jean Ford - Dept of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, USA )
7 May 2009

AACR 2009: MicroRNA profiles of colorectal adenocarcinomas

Dr Upender Manne - Associate Professor of Pathology, Birmingham School of Medicine, University of Albama, USA
AACR 2009: MicroRNA profiles of colorectal adenocarcinomas ( Dr Upender Manne - Associate Professor of Pathology, Birmingham School of Medicine, University of Albama, USA )
7 May 2009

AACR 2009: Caucasian-american and african-american breast cancer risk factors

Prof Yong Cui - Department of Internal Medicine, Meharry Medical College, USA
AACR 2009: Caucasian-american and african-american breast cancer risk factors ( Prof Yong Cui - Department of Internal Medicine, Meharry Medical College, USA )
7 May 2009

AACR 2009: Identification of the EGFRvIII Mutation in Glioblastoma

Prof. Donald O'Rourke - Associate Professor of Neurosurgery, University of Pennsylvania
AACR 2009: Identification of the EGFRvIII Mutation in Glioblastoma ( Prof. Donald O'Rourke - Associate Professor of Neurosurgery, University of Pennsylvania )
1 May 2009

AACR 2009: Molecular profiling of tumours to find potential targets and treatments for refractory cancers

Dr Daniel Von Hoff - Chief Scientific Officer, Scottsdale Healthcare and U.S. Oncology Research
AACR 2009: Molecular profiling of tumours to find potential targets and treatments for refractory cancers ( Dr Daniel Von Hoff - Chief Scientific Officer, Scottsdale Healthcare and U.S. Oncology Research )
1 May 2009

AACR 2009: Genetic influences in response to EGFR for metastatic colorectal cancer

Frederica Di Nicolantonio - Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment, University of Turin Medical School, Italy
AACR 2009: Genetic influences in response to EGFR for metastatic colorectal cancer ( Frederica Di Nicolantonio - Laboratory of Molecular Genetics, Institute for Cancer Research and Treatment, University of Turin Medical School, Italy )
1 May 2009

AACR 2009: Ovarian cancer biomarkers

Prof. Daniel Cramer - Dept Obstetrics and Gynaecology, Brigham and Women's Hospital, Harvard Medical School, USA
AACR 2009: Ovarian cancer biomarkers ( Prof. Daniel Cramer - Dept Obstetrics and Gynaecology, Brigham and Women's Hospital, Harvard Medical School, USA )
1 May 2009

AACR 2009: Genetics of pleuropulmonary blastoma

Dr Dana Ashley Hill - Chief of Anatomic Pathology, Children's National Medical Center, USA
AACR 2009: Genetics of pleuropulmonary blastoma ( Dr Dana Ashley Hill - Chief of Anatomic Pathology, Children's National Medical Center, USA )
1 May 2009

AACR 2009: Preclinical Analysis of Combined PI3K and MEK Inhibition as a Strategy for the Treatment of Cancer

Dr Lori Friedman - Director, Cancer Signalling and Translational Oncology, Genentech
AACR 2009: Preclinical Analysis of Combined PI3K and MEK Inhibition as a Strategy for the Treatment of Cancer ( Dr Lori Friedman - Director, Cancer Signalling and Translational Oncology, Genentech )
30 Apr 2009

AACR 2009: Designer T-Cells tackle prostate cancer

Professor Richard Junghans - Associate Professor of Surgery and Medicine, Boston University School of Medicine, USA
AACR 2009: Designer T-Cells tackle prostate cancer ( Professor Richard Junghans - Associate Professor of Surgery and Medicine, Boston University School of Medicine, USA )
30 Apr 2009

AACR 2009: Genetic variants in microRNA processing pathway genes and ovarian cancer risk

Professor Xifeng Wu - Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, USA
AACR 2009: Genetic variants in microRNA processing pathway genes and ovarian cancer risk ( Professor Xifeng Wu - Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, USA )
30 Apr 2009

AACR 2009: Genetic susceptibility for chronic lymphocytic leukaemia

Professor Susan Slager - Division of Biostatistics, Mayo Clinic College of Medicine, USA
AACR 2009: Genetic susceptibility for chronic lymphocytic leukaemia ( Professor Susan Slager - Division of Biostatistics, Mayo Clinic College of Medicine, USA )
30 Apr 2009

AACR 2009: Genetic prostate cancer risk

Dr Sunita Setlur - Brigham and Women's Hospital, Harvard Medical School, USA
AACR 2009: Genetic prostate cancer risk ( Dr Sunita Setlur - Brigham and Women's Hospital, Harvard Medical School, USA )
30 Apr 2009

AACR 2009: DNA profiling for bladder cancer

Dr Gangning Liang - Associate Professor of Research, Department of Urology, University of Southern California
AACR 2009: DNA profiling for bladder cancer ( Dr Gangning Liang - Associate Professor of Research, Department of Urology, University of Southern California )
30 Apr 2009

AACR 2009: Membrane microfilter device for capture and characterisation of circulating tumour cells

Anthony Williams - Keck School of Medicine, University of Southern California
AACR 2009: Membrane microfilter device for capture and characterisation of circulating tumour cells ( Anthony Williams - Keck School of Medicine, University of Southern California )
30 Apr 2009

AACR 2009: DMC exerts antiangiogenic effects on the tumour vasculature

Professor Florence Hofman - Keck School of Medicine, University of Southern California
AACR 2009: DMC exerts antiangiogenic effects on the tumour vasculature ( Professor Florence Hofman - Keck School of Medicine, University of Southern California )
30 Apr 2009

AACR 2009: Combined Inhibition of Histone Deacetylase and mTOR: A Novel Therapeutic Approach for Pancreatic Cancer

Dr Mamta Gupta - Mayo Clinic Cancer Center, USA
AACR 2009: Combined Inhibition of Histone Deacetylase and mTOR: A Novel Therapeutic Approach for Pancreatic Cancer ( Dr Mamta Gupta - Mayo Clinic Cancer Center, USA )
30 Apr 2009

AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia (ALL) with Poor Outcome: A New Therapeutic Target in Resistant Disease

Dr Charles Mullighan - Department of Pathology, St Jude Children's Research Hospital
AACR 2009: Frequent JAK Mutations in Pediatric Acute Lymphoblastic Leukemia (ALL) with Poor Outcome: A New Therapeutic Target in Resistant Disease ( Dr Charles Mullighan - Department of Pathology, St Jude Children's Research Hospital )
30 Apr 2009

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation